A Randomized Open Label Parallel Group International Multicenter Phase III Study of Oral ZD1839 IRESSA Versus Intravenous Docetaxel TAXOTERE in Patients With Locally Advanced or Metastatic Recurrent Non Small Cell Lung Cancer who have Previously Received Platinum Based Chemotherapy 1839IL 0721